You might be interested in
Long Shortz
Long Shortz with Bioxyne: Cannabis pastilles in an Aussie first
Health & Biotech
ASX Quarterly Health Wrap: Bioxyne revenue up 77%, Radiopharm lists on Nasdaq
Health & Biotech
Stockhead TV
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, host Sarah Hughan tells all on Bioxyne (ASX:BXN) commercially producing Australia’s first pharmaceutical cannabis edibles under a GMP (Good Manufacturing Practice) certification.
The gummies contain THC which is a naturally occurring psychoactive compound from the cannabis plant.
Tune in to get the latest.
While Bioxyne is a Stockhead advertiser, it did not sponsor this content.